ENGN earnings date and last-quarter result: next report 2026-09-14, last quarter beat, P/E -1.40. Updated 2026-07-23.
enGene Holdings (ENGN) Research Hub
enGene Holdings (ENGN) trades on NASDAQ, CA in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 1.58 USD (+1.28%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.40, market cap 0.09B. This hub links to the full technical, earnings and options research available for ENGN.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, CA |
| Last close | 1.58 USD (+1.28%) |
| 52-week range | 1.54 USD – 2.079 USD |
| Trend regime | Range |
| 14-day RSI | 36.2 (Bearish) |
| Trailing P/E | -1.40 |
| Market cap | 0.09B |
| Dividend yield | 0.00% |
| Next earnings | 2026-09-14 |
Available research for ENGN
Covered Call on ENGN: how it works, illustrative setup around the real 1.58 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ENGN: how it works, illustrative setup around the real 1.58 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ENGN: how it works, illustrative setup around the real 1.58 USD price, max profit/loss, breakeven and when to use it. Educational.
ENGN technical analysis: range, last 1.58 USD, RSI 36.2, 52w range 1.54 USD–2.079 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ENGN in?
enGene Holdings (ENGN) is classified under Healthcare (Biotechnology), listed on NASDAQ, CA.
Is ENGN in an uptrend or downtrend?
As of 2026-10-26, ENGN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ENGN's trailing P/E ratio?
ENGN's trailing P/E is -1.40, with a market cap of 0.09B. See the earnings research page for full valuation detail.
When does ENGN next report earnings?
ENGN is next scheduled to report earnings on 2026-09-14.